Bis-phenylamides and bis-hydroxyindolamides of diethylenetriaminepentaacetic acid-gadolinium (DTPA(Gd)) are paramagnetic reducing substrates of peroxidases that enable molecular imaging of peroxidase activity in vivo. Specifically, gadolinium chelates of bis-5-hydroxytryptamide-DTPA (bis-5HT-DTPA(Gd)) have been used to image localized inflammation in animal models by detecting neutrophil-derived myeloperoxidase (MPO) activity at the inflammation site. However, in other preclinical disease models, bis-5HT-DTPA(Gd) presents technical challenges due to its limited solubility in vivo. Here we report a novel MPO-sensing probe obtained by replacing the reducing substrate serotonin (5-HT) with 5-hydroxytryptophan (HTrp). Characterization of the resulting probe (bis-HTrp-DTPA(Gd)) in vitro using nuclear magnetic resonance spectroscopy and enzyme kinetic analysis showed that bis-HTrp-DTPA(Gd) (1) improves solubility in water; (2) acts as a substrate for both horseradish peroxidase and MPO enzymes; (3) induces cross-linking of proteins in the presence of MPO; (4) produces oxidation products, which bind to plasma proteins; and (5) unlike bis-5HT-DTPA(Gd), does not follow first-order reaction kinetics. In vivo magnetic resonance imaging (MRI) in mice demonstrated that bis-HTrp-DTPA(Gd) was retained for up to 5 days in MPO-containing sites and cleared faster than bis-5HT-DTPA(Gd) from MPOnegative sites. Bis-HTrp-DTPA(Gd) should offer improvements for MRI of MPO-mediated inflammation in vivo, especially in high-field MRI, which requires a higher dose of contrast agent.
M YELOPEROXIDASE (MPO) has emerged as a promising imaging target in molecular imaging. [1] [2] [3] [4] [5] MPO activity in vivo has a clear outcome-predictive value in several cardiovascular diseases, including myocardial infarction and stroke. 6 MPO has also been implicated in the progression of cancer, several central nervous system pathologies, and the development of unstable atheroma. 7, 8 Because the catalytic activity of MPO is preserved in live tissue either in intact granulocytes or as a component of exocytosed granules, the enzymatic activity of MPO can be used as an imaging marker of localized inflammation in vivo, including cardiovascular disease and vascular wall pathologies. 3, 9 We previously synthesized and tested several paramagnetic complexes of mono-and bis-amides of macrocyclic and linear polycarboxylic chelates that ''sense'' MPO activity. 1, 10, 11 These chelates carry heterocyclic hydroxyindole moieties, which donate electrons, thereby reducing peroxideoxidized MPO-I and MPO-II compounds to a catalytically active state. 12 The reactions of MPO with hydrogen peroxide and the following reduction of MPO-I and MPO-II can be written as follows: 
where A represents an aromatic (eg, indole) moiety and P is protein. Reaction schemes 1 and 2 illustrate the commonly observed MPO catalysis of hydrogen peroxide reduction that uses chloride anion for generating bactericidal hypochlorite as part of the inflammatory response following neutrophil infiltration and degranulation. Reactions 3 and 4 result in sequential reduction of MPO-I to ground-state MPO by hydroxyindole-containing compounds and tyrosine. Oxidized species generated from these reactions can react with proteins containing tyrosines (6) or can engage in either spontaneous dimerization (5) or oligomerization (7) . In the case of plant peroxidases, for example, horseradish peroxidase (HRP), reaction 2 is not catalyzed because chloride anion is not a reducing substrate of HRP. Paramagnetic hydroxindole-containing sensors apparently follow the same trend as other reducing organic compounds; that is, they dimerize, oligomerize, and/or form covalent bonds with proteins. Importantly, the latter two reactions result in increased molar relaxivity (r1 and r2) of the paramagnetic sensors. 1, 13, 14 This enables direct magnetic resonance imaging (MRI) of MPO activity in vivo because the products of the reaction are retained in the tissue for longer periods of time than the initial substrates. 2, 3, 5 Although some of the previously developed paramagnetic MPO sensors have very high kinetic stability, 14 the thermodynamic stability of bisamides is frequently compromised. Moreover, the solubility of neutrally charged (nonionic) bis-tryptamides of diethylenetriaminepentaacetic acid (DTPA) 10 and monoamides of glycyl-MeDOTA 1 in water is limited. Given that the amount of injected contrast agent needed to produce detectable contrast in MRIs is relatively high (0.1-0.3 mmol/kg), the need to improve the safety, enzymatic specificity, and formulation of MPO-sensing probes remains.
The goal of the current study was to synthesize and characterize an alternative charged bifunctional sensor of MPO activity with the same number of donor atoms as in DTPA (ie, three nitrogen/five oxygen configuration) in anticipation of improved thermodynamic stability and better solubility. We used a natural serotonin precursor, 5hydroxytryptophan (HTrp), which shares reactive oxygen species (ROS)-scavenging properties with serotonin 15 for synthesis of a novel paramagnetic DTPA diamide-based substrate.
Materials and Methods

Synthesis of Bis-HTrp-DTPA
Two grams (5.6 mmol) of diethylenetriaminepentaacetic dianhydride was reacted with 2.7 g (12.3 mmol) of L-5-HTrp in dry dimethylformamide in the presence of 1.0 g (12.5 mmol) of pyridine. The mixture was stirred at room temperature for 24 hours. The solvent was removed in vacuo. The crude product was solubilized in methanol and precipitated by slow acetone diffusion. The yield of pure product is 50%. Matrix-assisted laser desorption/ionization with ion trap mass spectrometry (MALDI-ITMS) analysis resulted in m/z 796.36 (C 36 
Syntheses of Gadolinium Chelates
Four grams (5.0 mmol) of bis-HTrp-DTPA was dissolved in 100 mL of 1% citric acid solution (pH 6.5). GdCl 3 .6H 2 O (1.1 eq.) was added in portions for 1 hour, and the solution was adjusted to pH 7.0 with 0.5 M NaOH solution. The mixture was stirred in dark under argon for 48 hours. The mixture was lyophilized. Final product was purified by high-performance liquid chromatography (HPLC) using a gradient of acetonitrile in water with 35% yield. Mass spectrometry measurements resulted in m/z value of 951.28 (M + 2H). The expected m/z value was 949.49 (which was based on formula C 36 H 38 N 7 O 14 Gd). Gadolinium chelates of bis-5-hydroxytryptamide-DTPA (bis-5HT-DTPA(Gd)) and bis-tyramide-DTPA were synthesized as described previously. 11, 14 All substrates were purified using C18-HPLC and lyophilized prior to use. Concentrations of gadolinium were measured using inductively coupled plasma-optical emission spectrometry (ICP-OES) (Galbraith Labs, Knoxville, TN).
Substrate Stability Measurements
Transmetallation of the gadolinium substrates (thermodynamic and kinetic indices) was measured and calculated as previously described. 16 Longitudinal and transverse relaxation rates were measured in phosphate buffer (pH 6.0 and pH 7.0) containing 2.5 mM of the substrate and 10 mL of 2.5 mM zinc chloride at different time points up to 3 days at 40uC.
Substrate Activation Studies
Initially, the substrates were dissolved in sterile Dulbecco's Phosphate Buffered Saline (DPBS), pH 7.4, for preparing 10 mM stock solutions. These stock solutions were further diluted to 0.1 to 1 mM in DPBS, pH 6.8, containing 5 mM glucose. The comparative substrate activation experiments were performed using glucose oxidase (GOX)/MPO or GOX/HRP (positive control) as complementing activitycoupled enzymatic pairs (3 IU GOX: 1.5 IU MPO or HRP, added directly to the reaction mixture). The enzymes were chemically deglycosylated and capped with hydroxylamine as previously described. 17 GOX was added to 0.5 mL of preheated (40uC) substrate solutions containing HRP or MPO in NMR spectroscopy tubes, and the solution was rapidly vortexed. The changes in T 1 and T 2 relaxation times were measured at 0.47 T using an inversion recovery (IR) and Carr-Purcell-Meiboom-Gill (CPMG) pulse sequences, respectively. The obtained time-course data were analyzed using Guggenheim approximation for pseudo-first-order kinetics. 18 The reaction mixtures were further analyzed using 4 to 15% gradient polyacrylamide gel electrophoresis (PAGE) (1 mg total protein/lane loaded), and the gels were stained with a silver stain kit (Thermo-Fisher, Waltham MA) to visualize both proteins and polymerized reaction products. Radioactive 111 Inlabeled analogues of bis-HTrp-DTPA and bis-5HT-DTPA ligands were synthesized by transchelating 111 In 3+ from 111 In citrate (obtained by diluting 111 InCl 3 stock solution [1 mCi; Perkin-Elmer, Waltham, MA] in 0.01 M sodium citrate, pH 5.5, and adding a 50-fold molar excess of HPLC-purified ligand followed by heating for 5 minutes at 50uC. The remaining free chelating groups were blocked by adding 1.1-fold molar excess of GdCl 3 , and the radiolabeled substrates were purified using C18-HPLC column (Discovery 5 mm, Supelco, Bellefoonte, PA) with an acetonitrile/water gradient. The main radioactive peaks were collected and dried under argon for further experiments.
Protein Binding Experiments
Heparinized human blood was centrifuged at 10,000g for 15 minutes followed by filtration through a 0.4 mm polyvinylidene difluoride filter to obtain cell-free total blood plasma. Gradient sodium dodecyl sulfate (SDS)-PAGE (4-15%) was performed using samples incubated in the presence or absence of the substrates to determine potential protein cross-linking using silver staining.
An aliquot containing 150 mCi of 111 In-labeled substrate (0.5 mL) was mixed with 20 mL of 1 mM ligand solution in 10 mM sodium acetate/citrate, pH 6.0, followed by 10 mL of MPO/GOX or HRP/GOX mixture. Control samples had no enzymes added. The reactions were initiated by diluting the above mixtures with either 10 mL of 43-Hank's Balanced Salt Solution (with Ca and Mg), pH 8, or with 10 mL of human plasma. After 30 minutes' incubation at 37uC, 50 mL aliquots of reaction mixtures were loaded on Bio-Spin P-6 columns (Bio-Rad, Hercules, CA), and the protein fraction was recovered in the spin-through eluate. The bound versus total radioactivity fractions were determined by counting 111 In radioactivity using the eluate and the remaining column in a dose calibrator (Bicron Instruments Newbury, OH). The aliquots of the eluates (20 mg total plasma protein) or equivalent volumes of control samples that did not contain plasma were loaded on 4 to 15% gradient PAGE, and the resultant gels were stained with GelCode Blue stain reagent (Thermo-Fisher), dried, and subjected to autoradiography using BioMAX MS film (Carestream Health, Rochester, NY).
MRI In Vivo and In Vitro at 3 T
All animal experiments were performed as approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Massachusetts Medical School (Worcester, MA). Imaging of MPO activity was performed in a model system as previously described 2 with modifications. Briefly, DBA/2 female mice (NCI-Frederick, Frederick, MD) (n 5 7), weighing 20 to 25 g, were injected with 200 mL of Matrigel (BD Biosciences, Bedford, MA) containing an MPO (7.5 IU)/GOX (5 IU) mixture in the left femoral muscle region, whereas the contralateral side, which served as the control, received Matrigel (200 mL) containing 5 IU GOX only. The animals were then imaged using MRI. Throughout the imaging sessions, animals were anesthetized using 1% isofluorane in an oxygen gas mixture. The lower body of the mouse was placed in a custom-made holder and then positioned in a 38 mm diameter, 55 mm long birdcage radiofrequency (RF) coil with a nose cone such that the thigh region was in the center of the coil. A circulating water heating blanket was placed under the mouse/RF coil assembly. For administration of contrast agent, a 29-gauge polyurethane catheter (Strategic Applications, Libertyville, IL) capped with a needle port was placed in the tail vein. A respiratory sensor was placed on the chest area to monitor the respiration rate throughout the imaging session.
All MRI measurements were performed using a Philips Achieva 3.0 T/60 cm console (Andover, MA) equipped with 80 mT/m actively shielded gradients. To monitor the temporal evolution of signal enhancement in the right and left femoral muscles following contrast agent delivery, multislice, T 1 -weighted (T 1 -W) MRIs (repetition time [TR]/echo time [TE] 5 700/8 ms) were acquired using spin-echo sequence at various time points after contrast agent administration. Other imaging parameters were slice thickness 5 1 mm; slice separation (center to center) 5 1.1 mm; field of view (FOV) 5 30 mm 3 30 mm; data acquisition matrix 5 320 3 320; number of averages (NEX) 5 4. Within an hour after implantation of Matrigel mixtures, precontrast images were acquired followed by intravenous injection of 0.2 mmol/kg bis-HTrp-DTPA(Gd). Several T 1 -W images were then acquired every 15 minutes up to the first hour and then at longer time intervals up to 5 days. Precontrast T 2 -W images were acquired prior to contrast administration to corroborate the presence of Matrigel mixture in the T 1 -W slices. T 2 -W imaging was performed using multislice, multi-spin-echo imaging with TR 5 1,380 ms and NEX 5 2. Eight echoes were acquired with intervening TE values of 25 ms. In vivo T 2 -W imaging was performed with the same FOV, data acquisition matrix, slice thickness, slice separation, and slice position as the in vivo T 1 -W images. Imaging of the in vitro phantom samples was done using a spin-echo sequence with TR/TE 5 200/30 ms and NEX 5 1.
Data Analysis
We quantitated the results obtained in two mice injected with identical specific activity of MPO and GOX. The signal decay in the femoral muscle following administration of bis-HTrp-DTPA(Gd) was evaluated for both MPOtreated and untreated (control) sides. Depending on the size of the implant, 5 to 14 imaging slices were selected at each time point covering the entire area of the implant corroborated using the T 2 images. The ImageJ software package (National Institutes of Health, Bethesda, MD) was used to construct a region of interest (ROI) around the boundary of the implants. The mean signal intensity (SI) values within each ROI were calculated using ImageJ. Contrast to noise ratios (CNRs) were then calculated using the following equation:
where CNR MPO/control is the CNR of the MPO or control side, SI MPO/control is the mean signal intensity, SI muscle is the mean signal intensity of muscle, and SD noise is the standard deviation of noise in the corresponding slice. Analysis of variance (ANOVA) for mixed models was used to determine if there was a significant change in CNR between the MPO-treated and control sides. The Tukey-Kramer honestly significant difference multiple comparisons procedure was used to determine if any significant differences existed between the MPO-treated and control sides. Statistical analyses were carried out using the SAS statistical software package (SAS Institute, Cary, NC).
Results
In Vitro Stability and Relaxivity
The gadolinium (III) chelate of bis-HTrp-DTPA(Gd) (substrate I, Figure 1 ) showed excellent solubility in water, DPBS, or 0.9% NaCl at concentrations up to 40 mg/mL (42 mM), whereas bis-5HT-DTPA(Gd) (substrate II, Figure 1B ) showed a solubility limit of approximately 30 mg/mL in 5% dimeglumine in DPBS and dissolved only with heating above 60uC (with the compound being precipitated from solution after returning to room temperature). Longitudinal relaxation time measurements at 0.47 T, 40uC showed that the r1 of substrates I and II were very similar (4.9 and 5.0 [mM . s] 21 , respectively). Purified I and II were further tested as reducing substrates in peroxidase-mediated reactions in the presence of D-glucose and GOX. End-point relaxivity measurements of reaction mixtures showed a similar increase in r1 value for both I and II (Table 1 and Figure  2 ) in the presence of either HRP or MPO (1.7-and 1.8fold, respectively, at 0.47 T). Measurements of kinetic and thermodynamic stability, when obtained under conditions of normal tissue pH (pH 7.0) or tissue acidosis (pH 6.0), revealed that substrate II was a more stable chelate of gadolinium when compared to other bis-amides of DTPA(Gd) used in this study ( Table 2) .
Reaction Kinetics
Longitudinal and transverse relaxation rate measurements (R1 and R2) at different substrate concentrations showed a concentration dependence of both longitudinal and transverse pseudo-first-order kinetic constants for substrate I but not for substrate II (see Table 1 ). We further compared the effective pseudo-first-order constants of cumulative relaxivity change reactions under the conditions of continuous enzyme cycling, that is, steady-state kinetics. The reactions were triggered by H 2 O 2 generation via a GOX/glucose system that allowed measurements of pseudo-first-order kinetic constants to be made by tracking the concentration dependence of the reaction rates. In the case of HRP, the enzyme-mediated relaxivity change showed that the pseudo-first-order kinetic constants depended on the concentration of bis-tyramide-DTPA(Gd) (substrate III, a positive control for HRP). The reaction of HRP with substrate II showed independence of the effective reaction rate constant on concentration, suggesting that the measurements of relaxivity change rates were dependent only on the concentration of the enzyme in the studied range of substrate concentrations. MPO-mediated catalysis of the high-relaxivity products was also independent of the concentration of substrate II. The effective pseudofirst-order reaction constants were approximately 20-fold lower in the case of MPO compared to HRP. Conversely, when substrate I was tested in reactions with both enzymes, we observed more rapid second-order kinetics of R1 and R2 increase in the case of MPO compared to HRP.
A direct comparison of the kinetics of relaxivity increase to the kinetics of oxidized product formation was performed by measuring the change in absorbance at 350 nm (Figure 3 ). The goal was to find out whether changes occurring during reactions 5, 6, and 7 (see above), that is, downstream from the formation of the total pool of DTPA(Gd)-linked oxidized aromatic groups, happen in concert with the reduction of MPO-II or HRP-II by the paramagnetic substrates. Both MPO and HRP reaction rates followed a linear dependence on substrate concentration (r 2 range .85-.9) in the presence of H 2 O 2 (0.2 mM). 19 MPO showed much lower kinetic constant values in the case of substrate II (which reduces both HRP-II and MPO-II), reflecting the overall slow rate of MPO reaction, which was about 10-fold slower than that catalyzed by HRP (see Table 1 ).
Interaction of the Reaction Products with Proteins
Gradient PAGE analysis of the substrates and reaction mixtures with peroxidases and GOX showed that HRP reaction products formed within 15 minutes of incubation. We observed a higher mass spot above the band corresponding to substrate I (Figure 4, lane 4) . The optical density of this spot increased after a 2-hour incubation with HRP and GOX mixture (data not shown). The nonreacted substrates migrated with the front of the gel. In the case of MPO, there was no apparent formation of higher-molecular-weight oligomerized products (Figure 4 -8) showed high-molecular-weight condensation products in both HRP-and MPO-containing reaction mixtures, with the former enzyme catalyzing approximately eight times the amount of the oligomerized product. No protein cross-linking was present in these reaction mixtures.
To determine enzymatic reaction efficacy in the presence of serum proteins and to determine whether the serum proteins bind the chelates directly, we labeled the initial chelates (ie, bis-5HT-DTPA and bis-HTrp-DTPA) with 111 In isotope and measured the accumulation of reaction products in vitro. The radioactivity in eluates of the columns is shown in Table 3 . We determined that both substrates I and II bind to plasma proteins at very low levels (not exceeding 0.5%) in the absence of peroxidases. In the absence of plasma proteins, a reaction mixture containing MPO/GOX resulted in 5 to 6% eluted radioactivity, suggesting low levels of oligomerization with the formation of a high-molecular-mass fraction. In contrast, HRP resulted in 30% of the substrates converting into a high-molecular-mass (. 6 kDa) fraction of radioactive products. Both MPO and HRP catalyzed the formation of products that were bound to plasma proteins as confirmed by adding plasma proteins to the reactions and separating the obtained products (see Table 3 ). The MPO-catalyzed reaction resulted in approximately three times more binding of substrate II products to plasma proteins than substrate I (14% vs 50%; see Table 3 ), whereas the HRPcatalyzed reaction resulted in approximately equal amounts of radioactivity eluted in the void volume together with plasma proteins (50-60%).
Autoradiography was used to analysis reaction products after labeling the substrates with 111 In, and lowmolecular-weight products were resolved by gradient SDSelectrophoresis. The products of MPO in reaction with substrate I resulted in hydrophilic products that were poorly retained in the gel. The main plasma component that was labeled during substrate II oxidation was serum albumin ( Figure 5 ). HRP showed much more efficient oligomerization of substrate II if compared to substrate I. The distribution of radioactivity associated with plasma proteins in the case of both substrate I and II reactions with HRP was very similar (see Figure 5 ). Serum albumin and an unidentified 200 kDa protein were the main binding partners for oxidized substrates. Both products of substrate I and II bind to plasma proteins; however, the binding is lower in the case of MPO/substrate I combination than in other tested substrate/enzyme combinations.
In Vivo Imaging of MPO Activity Using Substrate I
The capability of bis-HTrp-DTPA(Gd) to generate magnetic resonance signal enhancement at sites of localized MPO activity in vivo was assessed in mice. Animals received bilateral femoral muscle implants of basement membrane matrix gel (Matrigel) containing either an MPO (7.5 IU)/GOX (5 IU) mixture (left femoral muscle, denoted by the asterisk in Figure 6A ) or 5 IU GOX only (right femoral muscle), which served as the control. Figure 6A shows sequential T 1 -W images depicting implant enhancement as a function of time following intravenous injection of bis-HTrp-DTPA(Gd). Strong initial signal enhancement was observed in both MPO active and control femoral muscle implants. However, in control implants, the initial enhancement steadily decreased over time and was barely visible 4 hours after contrast injection, whereas the enhancement of MPO active implants persisted, even after 5 days (p , .0001) ( Figure 6B ). A similar time-dependent course of magnetic resonance signal enhancement was observed in animals that were injected with a 10-fold lower MPO dose (data not shown).
Discussion
Noninvasive imaging of MPO activity can be performed by using high anatomic resolution MRI, 2 high-sensitivity single-photon emission computed tomography (SPECT), 20 or bioluminescence. 4 MPO activity can be detected and monitored in tissues during the initiation and progression of diseases such as atherosclerosis, 3 myocardial infarction, 9 stroke, 21 and autoimmune encephalitis. 22 The precise localization of MPO-containing lesions is enabled by paramagnetic low-molecular-weight substrates, which are mono-or bis-amides of linear or cyclic chelates. 1, 10 Rapid progress in the development of high-field MRI dictates the need for MPO-sensing probes that can be injected at higher doses than previously developed bisamide-based probes, which have relatively low solubility and can be injected only at low doses. This study examined the potential benefits of replacing previously used 5-HT with HTrp in the synthesis of a magnetic resonance-detectable MPO probe. The newly synthesized probe demonstrated greater solubility in aqueous solutions and produced gradual increases in proton relaxation rates (R1 and R2) in the presence of either MPO or HRP with the addition of H 2 O 2 . Interestingly, the oxidation of charged bis-HTrp-DTPA(Gd) (substrate I) by HRP resulted in a less efficient reactive intermediate than the nonionic bis-5HT-DTPA(Gd) (substrate II). Conversely, the reactions catalyzed by MPO resulted in a more rapid proton relaxation rate increase in the presence of substrate I. The observed substrate (I vs II) and enzyme (HRP vs MPO) -dependent differences in the kinetics of R1 and R2 changes raise two important questions: (1) are the observed differences in reaction constants due to the reaction being limited by the formation of oxidized reactive groups (ie, the efficiency of reduction of oxidized enzymes) and (2) are the observed results related to variations in substrate I-and substrate II-generated products? To address these questions, we determined the kinetics of the enzyme-catalyzed reactions. An analysis of reaction products and the resultant protein reaction mixtures suggests that the reaction products of HRP reduction were not rate limiting, whereas MPO generated oxidized intermediates at a much slower rate, which could be rate limiting for a substrate II-mediated rise in relaxivity of the reaction products. In addition, we found that the products of HRP versus MPO reactions were entirely different. Whereas enzyme-mediated oxidation of both substrates I and II resulted in products that showed binding to plasma proteins (see Table 3 ), only MPOoxidized substrate I resulted in detectable cross-linking of GOX, which was used as a source of H 2 O 2 in the reaction mixture (see Figure 4 ). The significance of this finding lies in the fact that cross-linking, as opposed to the formation of smaller paramagnetic oligomers, can potentially result in a higher relaxivity increase per reacting Gd-labeled paramagnetic chelate due to the effect of Gd immobilization and the resultant increase in rotational correlation time. 23, 24 The formation of such products in blood plasma protein solutions will likely depend on the number of exposed tyrosines and the degree of protein solvation and will require further investigation.
In vivo experiments performed after implantation of MPO-positive and MPO-negative Matrigel mixtures into the flanks of mice demonstrated that magnetic resonance signal enhancement on T 1 -W images was substantially long-lasting in MPO-containing muscle implants. This is likely due to retention of paramagnetic MPO-generated reaction products, which results from the cross-linking of proteins in the Matrigel matrix, as characterized by us previously. 2, 17, 25 Using bis-5HT-DTPA as the substrate, Chen and colleagues and Nahrendorf and colleagues observed similar results in vivo in injured myocardium and in extremity implants, respectively, where the wash-in Figure 5 . Gradient PAGE (4-15%) analysis of 111 In-labeled substratecontaining mixtures in the absence and presence of blood plasma proteins. Fifty microliters of Bio-Spin P-6 eluates (see Table 2 ) were loaded on a gel CNR curve reached a maximum at around the 1-hour time point and was still present after 200 minutes. 2, 9 In the current study, we observed an increase in the magnetic resonance CNR during wash-in of bis-HTrp-DTPA(Gd), which reached a maximum during the first hour and then a gradual decrease (washout) of CNR over the next 5 days. This may be due to a combined effect of less efficient oligomerization of substrate I than substrate II in the presence of MPO and the solubility of the resultant oligomers.
Conclusion
The synthesis of bis-HTrp-DTPA(Gd) resulted in a new MPO-sensitive MRI probe that produced an increase in Gd-induced proton relaxation rates similar to that of bis-5HT-DTPA(Gd). The new probe has high solubility in aqueous media at room temperature, making it preferable for applications requiring higher in vivo probe concentrations (ie, mouse imaging at higher magnetic fields, reviewed in Sosnovik and colleagues 26 ) . Kinetic experiments demonstrated that although both MPO and HRP reacted with both substrates, there were notable differences in terms of the type of reaction products formed: substrate II and HRP gave insoluble cross-linked final products if the reaction proceeded for several hours, whereas the products of substrate I were soluble. Gradient SDS-PAGE analysis of enzymatic activation of substrate I showed the formation of a 10 to 20 kDa oligomerized product in the case of HRP, whereas in the reaction mixture containing MPO, we observed the formation of cross-linked proteins. The binding of the reactive products after the substrate activation by MPO was also detected in the presence of plasma proteins. This suggests that protein binding in the case of substrate I reaction with MPO can potentially compensate for the lack of extensive oligomerization. Despite lower stability of substrate II, especially under conditions modeling Figure 6 . Magnetic resonance imaging of mouse femoral muscle at 3 T with implanted Matrigel and MPO/ GOX mixture. A, T 1 -weighted sequential mouse extremity images are shown following intravenous injection of bis-HTrp-DTPA(Gd) depicting MPO/GOX enhancement (due to formation of cross-linked products) as a function of time in the left femoral muscle region (indicated with an asterisk), whereas the contralateral side implanted with Matrigel served as the control. Time intervals after the injection of bis-HTrp-DTPA(Gd) are shown above each image. Regions of interest were selected for all time points as indicated in the 1-hour time point slice. The signal intensities from all time points were normalized to precontrast slice and are thus directly comparable, B, Relative contrast to noise ratio (CNR) curves showing enhancement in the femoral muscle of two mice are shown as a function of time following intravenous injection of bis-HTrp-DTPA(Gd). For each animal, the temporal wash-in and washout of bis-HTrp-DTPA(Gd) signal enhancement is shown in the MPO-treated muscle (filled triangles and diamonds) and the untreated control side (empty triangles and diamonds). These plots were derived from several slices in each animal at each time point. Within each animal, the CNR is normalized to the maximum value to compute relative CNR. tissue acidosis, we anticipate it to be an efficient sensor for in vivo imaging of MPO activity due to potential linking of the corresponding reaction products to tissue proteins in inflammatory lesions.
